Microglia, amyloid, and cognition in Alzheimer's disease: An [11C](R)PK11195-PET and [11C]PIB-PET study

Clinical diagnosis of Alzheimer's disease: Report of the NINCDS‐ADRDA Work Group* under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915

Neuropathological stageing of Alzheimer-related changes.

Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123

Inflammation and Alzheimer’s disease

Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B

Klunk, W. E., Engler, H., Nordberg, A., Wang, Y., Blomqvist, G., Holt, D. P., Bergström, M., Savitcheva, I., Huang, G., Estrada, S., et al. (2004) · Annals of Neurology · doi:10.1002/ana.20009 · Cited by 4,496

Microglia: a sensor for pathological events in the CNS

Kreutzberg, G. W. (1996) · Trends in Neurosciences · doi:10.1016/0166-2236(96)10049-7 · Cited by 4,396

Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse

Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., et al. (1999) · Nature · doi:10.1038/22124 · Cited by 3,160

The molecular pathology of Alzheimer's disease

Selkoe, D. J. (1991) · Neuron · doi:10.1016/0896-6273(91)90052-2 · Cited by 2,708

Amyloid deposition as the central event in the aetiology of Alzheimer’s disease

Hardy, J., & Allsop, D. (1991) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(91)90609-v · Cited by 2,538

Synapse Loss and Microglial Activation Precede Tangles in a P301S Tauopathy Mouse Model

Yoshiyama, Y., Higuchi, M., Zhang, B., Huang, S.-M., Iwata, N., Saido, T. C., Maeda, J., Suhara, T., Trojanowski, J. Q., & Lee, V. M.-Y. (2007) · Neuron · doi:10.1016/j.neuron.2007.01.010 · Cited by 2,208

Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease

Bard, F., Cannon, C., Barbour, R., Burke, R.-L., Games, D., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., et al. (2000) · Nature Medicine · doi:10.1038/78682 · Cited by 2,012

A dual GLP-1 and Gcg receptor agonist rescues spatial memory and synaptic plasticity in APP/PS1 transgenic mice

Wang, Z.-J., Han, Y., Zhao, F., Yang, G., Yuan, L., Cai, H.-Y., Yang, J., Hölscher, C., Qi, J., & Wu, M. (2019) · Hormones and Behavior · doi:10.1016/j.yhbeh.2019.104640 · Cited by 23

N-3 polyunsaturated fatty acid and neuroinflammation in aging and Alzheimer's disease

Layé, S., Madore, C., St‐Amour, I., Delpech, J.-C., Joffre, C., Nadjar, A., & Calon, F. (2015) · Nutrition and Aging · doi:10.3233/nua-150049 · Cited by 24

Mapping brain β-amyloid

Jagust, W. J. (2009) · Current Opinion in Neurology · doi:10.1097/wco.0b013e32832d93c7 · Cited by 23

Naoling decoction restores cognitive function by inhibiting the neuroinflammatory network in a rat model of Alzheimer’s disease

Xia, Z., Peng, W., Cheng, S., Zhong, B., Sheng, C., Zhang, C., Gong, W., Cheng, S., Li, J., & Wang, Z. (2017) · Oncotarget · doi:10.18632/oncotarget.17337 · Cited by 23

Therapeutic potential to target sialylation and SIGLECs in neurodegenerative and psychiatric diseases

Wißfeld, J., Assale, T. A., Cuevas-Ríos, G., Liao, H., & Neumann, H. (2024) · Frontiers in Neurology · doi:10.3389/fneur.2024.1330874 · Cited by 23

Advances in PET Imaging of Degenerative, Cerebrovascular, and Traumatic Causes of Dementia

Eisenmenger, L. B., Huo, E. J., Hoffman, J. M., Minoshima, S., Matesan, M. C., Lewis, D. H., Lopresti, B. J., Mathis, C. A., Okonkwo, D. O., & Mountz, J. M. (2015) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2015.09.003 · Cited by 21

Molecular imaging as a guide for the treatment of central nervous system disorders

Kim, E., Howes, O. D., & Kapur, S. (2013) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2013.15.3/ekim · Cited by 22

Future Directions in Imaging Neurodegeneration

Masdeu, J. C. (2017) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-017-0718-1 · Cited by 22

Incretin Hormones GLP-1 and GIP Normalize Energy Utilization and Reduce Inflammation in the Brain in Alzheimer’s Disease and Parkinson’s Disease: From Repurposed GLP-1 Receptor Agonists to Novel Dual GLP-1/GIP Receptor Agonists as Potential Disease-Modifying Therapies

Hölscher, C. (2025) · CNS Drugs · doi:10.1007/s40263-025-01226-z · Cited by 26

Summative effects of vascular risk factors on cortical thickness in mild cognitive impairment

Tchistiakova, E., & MacIntosh, B. J. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.05.011 · Cited by 21

Expression of Phenotypic Astrocyte Marker Is Increased in a Transgenic Mouse Model of Alzheimer’s Disease versus Age-Matched Controls: A Presymptomatic Stage Study

Doméné, A., Cavanagh, C., Page, G., Bodard, S., Klein, C., Delarasse, C., Chalon, S., & Krantic, S. M. (2016) · International Journal of Alzheimer s Disease · doi:10.1155/2016/5696241 · Cited by 21

Imaging the Role of GABA in Movement Disorders

Boecker, H. (2013) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-013-0385-9 · Cited by 21

Do Microglia default on network maintenance in Alzheimer's disease?

Southam, K. A., Vincent, A. J., & Small, D. H. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-151075 · Cited by 20

Demystifying the Role of Neuroinflammatory Mediators as Biomarkers for Diagnosis, Prognosis, and Treatment of Alzheimer’s Disease: A Review

Doke, R. R., Lamkhade, G., Vinchurkar, K., & Singh, S. K. (2024) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.4c00457 · Cited by 24

PET Neuroimaging in Dementia Conditions

Perani, D., Caminiti, S. P., Carli, G., & Tondo, G. (2020) · Springer eBooks · doi:10.1007/978-3-030-53168-3_9 · Cited by 20

Advances in CNS Imaging Agents: Focus on PET and SPECT Tracers in Experimental and Clinical Use

George, N., Gean, E. G., Nandi, A., Фролов, Б. А., Zaidi, E., Lee, H., Brašić, J. R., & Wong, D. F. (2015) · CNS Drugs · doi:10.1007/s40263-015-0237-z · Cited by 21

Genetic Therapies for Alzheimer’s Disease: A Scoping Review

Lennon, M. J., Rigney, G., Raymont, V., & Sachdev, P. S. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-215145 · Cited by 23

The development status of PET radiotracers for evaluating neuroinflammation

Lee, N., Choi, J. Y., & Ryu, Y. H. (2024) · Nuclear Medicine and Molecular Imaging · doi:10.1007/s13139-023-00831-4 · Cited by 21

Peripheral α-Defensins 1 and 2 are Elevated in Alzheimer's Disease

Watt, A. D., Perez, K. A., Ang, C., O’Donnell, P. A., Rembach, A., Pertile, K. K., Rumble, R. L., Trounson, B. O., Fowler, C. J., Faux, N. G., et al. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-142286 · Cited by 19

The translocator protein as a drug target in Alzheimer’s disease

Chua, S. W., Kassiou, M., & Ittner, L. M. (2014) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2014.896201 · Cited by 20

In-vivo visualization of key molecular processes involved in Alzheimer's disease pathogenesis: Insights from neuroimaging research in humans and rodent models

Higuchi, M., Maeda, J., Ji, B., Maruyama, M., Okauchi, T., Tokunaga, M., Ono, M., & Suhara, T. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.01.003 · Cited by 20

Reprint of: Microglial toll-like receptors and Alzheimer’s disease

Su, F., Bai, F., Zhou, H., & Zhang, Z. (2016) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2016.05.016 · Cited by 19

Milrinone in the treatment of low output states following cardiac surgery.

WRIGHT, E. M., Skoyles, J., & SHERRY, K. M. (1992) · PubMed · Cited by 20

Sex differences and the role of estrogens in the immunological underpinnings of Alzheimer's disease

Price, B. R., Walker, K. A., Eissman, J. M., Suryadevara, V., Sime, L. N., Hohman, T. J., & Gordon, M. N. (2025) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.70139 · Cited by 25

Amyloid-β Immunotherapy Reduces Amyloid Plaques and Astroglial Reaction in Aged Domestic Dogs

Bosch, M. N., Pugliese, M., Andrade, C., Gimeno‐Bayón, J., Mahy, N., & Rodríguez, M. J. (2014) · Neurodegenerative Diseases · doi:10.1159/000368672 · Cited by 19

Over-expression of TSPO in the hippocampal CA1 area alleviates cognitive dysfunction caused by lipopolysaccharide in mice

Zhang, H., Ma, L., Yin, Y., Dong, L.-Q., Cheng, G., Ma, Y., Li, Y., & Xu, B. (2016) · Brain Research · doi:10.1016/j.brainres.2016.06.001 · Cited by 19

Mapping of Translocator Protein (18 kDa) in Peripheral Sterile Inflammatory Disease and Cancer through PET Imaging

Adhikari, A., Singh, P., Mahar, K. S., Adhikari, M., Adhikari, B., Zhang, M., & Tiwari, A. K. (2021) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.1c00002 · Cited by 19

Sex Differences in Locus Coeruleus: A Heuristic Approach That May Explain the Increased Risk of Alzheimer’s Disease in Females

Luckey, A. M., Robertson, I. H., LAWLOR, B. A., Mohan, A., & Vanneste, S. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210404 · Cited by 24

Voxel-Based Analysis of Amyloid-Burden Measured with [11C]PiB PET in a Double Transgenic Mouse Model of Alzheimer’s Disease

von Reutern, B., Grünecker, B., Yousefi, B. H., Henriksen, G., Czisch, M., & Drzezga, A. E. (2013) · Molecular Imaging and Biology · doi:10.1007/s11307-013-0625-z · Cited by 17

Investigating the Spatial Associations Between Amyloid-β Deposition, Grey Matter Volume, and Neuroinflammation in Alzheimer’s Disease

Jorge, L., Martins, R., Canário, N., Xavier, A. C., Abrunhosa, A., Santana, I. J., & Castelo-Branco, M. S. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-200840 · Cited by 19

Analysis of Microglial Proliferation in Alzheimer’s Disease

Gómez‐Nicola, D., & Perry, V. H. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2627-5_10 · Cited by 18

Peripheral inflammatory markers in amnestic mild cognitive impairment

Karim, S., Hopkins, S., Purandare, N. B., Crowther, J., Morris, J., Tyrrell, P. J., & Burns, A. S. (2013) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.3988 · Cited by 18

Advances in molecular imaging for the diagnosis of dementia

Okamura, N., Fodero‐Tavoletti, M. T., Kudo, Y., Rowe, C. C., Furumoto, S., Arai, H., Masters, C. L., Yanai, K., & Villemagne, V. L. (2009) · Expert Opinion on Medical Diagnostics · doi:10.1517/17530050903133790 · Cited by 18

Imaging neuroinflammation in Alzheimer’s and other dementias: recent advances and future directions

Brooks, D. J. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.01.049 · Cited by 17

Advanced brain imaging for the diagnosis of Alzheimer disease

Wang, Y.-T. T., Rosa‐Neto, P., & Gauthier, S. G. (2023) · Current Opinion in Neurology · doi:10.1097/wco.0000000000001198 · Cited by 16

Association between air pollution and CSF sTREM2 in cognitively normal older adults: The CABLE study

Li, M., Ma, Y., Fu, Y., Liu, J.-Y., Hu, H., Zhao, Y., Huang, L., & Tan, L. (2022) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51671 · Cited by 16

Chronically raised C-reactive protein is inversely associated with cortical β-amyloid in older adults with subjective memory complaints

Hooper, C., Barreto, P. D. S., Cantet, C., Cesari, M., Payoux, P., Salabert, A., & Vellas, B. J. (2018) · Experimental Gerontology · doi:10.1016/j.exger.2018.04.014 · Cited by 19

Pursuit of precision medicine: Systems biology approaches in Alzheimer's disease mouse models

Gurdon, B., & Kaczorowski, C. C. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105558 · Cited by 16

Beyond monoamines: I. Novel targets and radiotracers for Positron emission tomography imaging in psychiatric disorders

Lopresti, B. J., Royse, S. K., Mathis, C. A., Tollefson, S., & Narendran, R. (2022) · Journal of Neurochemistry · doi:10.1111/jnc.15615 · Cited by 16

4'-Chlorodiazepam is neuroprotective against amyloid-beta through the modulation of survivin and bax protein expression in vitro.

Arbo, B. D., Marques, C. V., Ruiz-Palmero, I., Ortiz-Rodriguez, A., Ghorbanpoor, S., Arevalo, M., Garcia-Segura, L., & Ribeiro, M. (2016) · Brain Research · doi:10.1016/j.brainres.2015.12.018 · Cited by 2

Three-way interaction model to trace the mechanisms involved in Alzheimer’s disease transgenic mice

Khayer, N., Marashi, S., Mirzaie, M., & Goshadrou, F. (2017) · PLoS ONE · doi:10.1371/journal.pone.0184697 · Cited by 16

PET Imaging to Measure Neuroinflammation In Vivo

Malpetti, M., Franzmeier, N., & Brendel, M. (2024) · Methods in molecular biology · doi:10.1007/978-1-0716-3774-6_12 · Cited by 14

Time-Dependent Compensatory Responses to Chronic Neuroinflammation in Hippocampus and Brainstem: The Potential Role of Glutamate Neurotransmission

Brothers, H. M. (2013) · Journal of Alzheimer’s Disease & Parkinsonism · doi:10.4172/2161-0460.1000110 · Cited by 15

Neuroimaging of Diseases Causing Dementia

Masdeu, J. C. (2019) · Neurologic Clinics · doi:10.1016/j.ncl.2019.08.003 · Cited by 16

A regional and cellular analysis of the early intracellular and extracellular accumulation of Aβ in the brain of 5XFAD mice

Daini, E., Secco, V., Liao, W., Zoli, M., & Vilella, A. (2021) · Neuroscience Letters · doi:10.1016/j.neulet.2021.135869 · Cited by 15

In Vivo Imaging Biomarkers in Mouse Models of Alzheimer's Disease: Are We Lost in Translation or Breaking Through?

Delatour, B., Epelbaum, S., Petiet, A., & Dhénain, M. (2010) · International Journal of Alzheimer s Disease · doi:10.4061/2010/604853 · Cited by 18

New PET markers for the diagnosis of dementia

Payoux, P., & Salabert, A. (2017) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000489 · Cited by 14

Self-assembling nanofibers alter the processing of amyloid precursor protein in a transgenic mouse model of Alzheimer’s disease

Yang, H., Yang, H., Xie, Z., Wang, P., & Bi, J. (2014) · Neurological Research · doi:10.1179/1743132814y.0000000417 · Cited by 14

Does the Interplay Between Aging and Neuroinflammation Modulate Alzheimer’s Disease Clinical Phenotypes? A Clinico-Pathological Perspective

Taipa, R. J. F., Sousa, A. L., Pires, M. M., & Sousa, N. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160121 · Cited by 15

A Protective Role of Translocator Protein in Alzheimer’s Disease Brain

Jung, M. E. (2020) · Current Alzheimer Research · doi:10.2174/1567205017666200217105950 · Cited by 17

Role of Glucagon-Like Peptide-1 on Amyloid, Tau, and α-Synuclein: Target Engagement and Rationale for the Development in Neurodegenerative Disorders

Au, H. C. T., Lam, P. H., Lim, P. K., & McIntyre, R. S. (2025) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2025.106159 · Cited by 14

Inflammation-Related microRNAs-146a and -155 Are Upregulated in Mild Cognitive Impairment Subjects Among Older Age Population in Montenegro

Dragović, I. R., Popović, N., Ždralević, M., Radulović, L., Vuković, T., Marzano, F., Tullo, A., & Radunović, M. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220676 · Cited by 17

Neurodegenerative Diseases

Gómez‐Nicola, D., & Perry, V. H. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1429-6_18 · Cited by 13

Neuroinflammatory mechanisms linking high‐fat diets to Alzheimer's disease vulnerability: Beyond the amyloid hypothesis

Mackey-Alfonso, S. E., & Barrientos, R. M. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70911 · Cited by 13

Image Quantification for TSPO PET with a Novel Image-Derived Input Function Method

Fang, Y.-H. D., McConathy, J., Yacoubian, T. A., Zhang, Y., Kennedy, R., & Standaert, D. G. (2022) · Diagnostics · doi:10.3390/diagnostics12051161 · Cited by 12

The longitudinal trajectory of CSF sTREM2: the alzheimer’s disease neuroimaging initiative

Wang, Y. T., Ye, M., Ji, Q., Liu, Q., Xu, X., & Zhan, Y. (2024) · Alzheimer s Research & Therapy · doi:10.1186/s13195-024-01506-8 · Cited by 13

The mitochondrial translocator protein (TSPO) in Alzheimer's disease: Therapeutic and immunomodulatory functions

Fairley, L. H., Lai, K. O., Grimm, A., Eckert, A., & Barron, A. M. (2024) · Biochimie · doi:10.1016/j.biochi.2024.07.003 · Cited by 14

Molecular imaging of neuroinflammation in Alzheimer’s disease

Varrone, A., & Nordberg, A. K. (2015) · Clinical and Translational Imaging · doi:10.1007/s40336-015-0137-8 · Cited by 13

The Protective Effect of PK-11195 on Cognitive Impairment in Rats Survived of Polymicrobial Sepsis

Dominguini, D., Steckert, A. V., Abatti, M. R., Generoso, J. S., Barichello, T., & Dal‐Pizzol, F. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02294-0 · Cited by 12

Dampening of Microglial Activation With Nasal Foralumab Administration in Moderate Alzheimer’s Disease Dementia

Singhal, T., Cicero, S., Gale, S. A., Horan, N., Dubey, S., Marshall, G. A., & Weiner, H. L. (2025) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000005955 · Cited by 12

Glial activation positron emission tomography imaging in radiation treatment of breast cancer brain metastases

Badiuk, S. R., Thiessen, J. D., Vareki, S. M., Foster, P. J., Chen, J. Z., & Wong, E. (2022) · Physics and Imaging in Radiation Oncology · doi:10.1016/j.phro.2022.02.016 · Cited by 12

Microglial responses partially mediate the effect of Aβ on cognition in Alzheimer's disease

Madsen, L. S., Ismail, R., Parbo, P., Kjeldsen, P. L., Schaldemose, J. L., Hansen, K. V., Gottrup, H., Aanerud, J., Eskildsen, S. F., & Brooks, D. J. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14298 · Cited by 13

Towards molecular imaging of multiple sclerosis

Owen, D. R., Piccini, P. P., & Matthews, P. M. (2011) · Multiple Sclerosis Journal · doi:10.1177/1352458510390070 · Cited by 11

Genetic factors related to the immune system in subjects at risk of developing Alzheimer's disease

Prendecki, M., Kowalska, M., Łagan-Jędrzejczyk, U., Piekut, T., Krokos, A., Kozubski, W. P., & Dorszewska, J. (2020) · Journal of Integrative Neuroscience · doi:10.31083/j.jin.2020.02.110 · Cited by 11

TSPO contributes to neuropathology and cognitive deficits in Alzheimer’s disease

Ceyzériat, K., Badina, A. M., Abjean, L., Meyer, L., Bouteldja, F., Bałkota, M., Amossé, Q., Prudhomme, O., Middleton, R. J., Liu, G.-J., et al. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03583-4 · Cited by 14

Neuroinflammation-Induced Memory Deficits Are Amenable to Treatment with d-Cycloserine

Zaltsman, S. L., Yaka, R., Shabashov, D., Shohami, E., & Biegon, A. R. (2016) · Journal of Molecular Neuroscience · doi:10.1007/s12031-016-0786-8 · Cited by 10

Review Article Neuroinflammation in Alzheimer's disease: Current evidence and future directions

Calsolaro, V., & Edison, P. (2016) · Cited by 10

Systematic Evaluation of Kinetics and Distribution of Muscle and Lymph Node Activation Measured by 18F-FDG- and 11C-PBR28-PET/CT Imaging, and Whole Blood and Muscle Transcriptomics After Immunization of Healthy Humans With Adjuvanted and Unadjuvanted Vaccines

Win, Z., rd, J. W., Listanco, A., Patel, N., Sharma, R., Greenwood, A., Maertzdorf, J., Mollenkopf, H., Pizzoferro, K., Cole, T., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.613496 · Cited by 10

The Brain Network Hub Degeneration in Alzheimer’s Disease

Jin, S., Wang, J., & Yong He, A. (2024) · Biophysics Reports · doi:10.52601/bpr.2024.230025 · Cited by 11

The Anti-Inflammatory Actions of Soluble Klotho in Brain Aging and Its Main Associated Diseases

López-Valdés, H. E., Hernández-Lucas, M., Rodríguez-Fabián, G. D. J., Esteban-Román, N. F., Gutiérrez-Juárez, R., Arrieta‐Cruz, I., & Martínez‐Coria, H. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26178551 · Cited by 10

Insulin resistance and body mass index are associated with TSPO PET in cognitively unimpaired elderly

Ekblad, L. L., Tuisku, J., Koivumäki, M., Helin, S., Rinne, J. O., & Snellman, A. (2023) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x231172519 · Cited by 10

Prefrontal Lobe Brain Reserve Capacity with Resistance to Higher Global Amyloid Load and White Matter Hyperintensity Burden in Mild Stage Alzheimer’s Disease

Chang, Y., Huang, C., Chen, N.-C., Lin, K., Huang, S., Chang, Y., Hsu, S., Chang, W., Lui, C., Hsu, C.-W., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0149056 · Cited by 8

Regional desynchronization of microglial activity is associated with cognitive decline in Alzheimer’s disease

Zatcepin, A., Gnörich, J. S., Rauchmann, B., Bartos, L. M., Wagner, S., Franzmeier, N., Malpetti, M., Xiang, X., Shi, Y., Parhizkar, S., et al. (2024) · Molecular Neurodegeneration · doi:10.1186/s13024-024-00752-6 · Cited by 8

Neue diagnostische Methoden bei Demenzen

Wiltfang, J. (2015) · Der Nervenarzt · doi:10.1007/s00115-014-4177-5 · Cited by 5

Mild Microglial Responses in the Cortex and Perivascular Macrophage Infiltration in Subcortical White Matter in Dogs with Age-Related Dementia Modelling Prodromal Alzheimer’s Disease

Thomsen, B. B., Madsen, C., Krohn, K. T., Thygesen, C., Schütt, T., Metaxas, A., Darvesh, S., Agerholm, J. S., Wirenfeldt, M., Berendt, M., et al. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210040 · Cited by 10

The ligands of translocator protein inhibit human Th1 responses and the rejection of murine skin allografts

Zhang, Y., Yu, S., Li, X., Yang, B., & Wu, C. Y. (2016) · Clinical Science · doi:10.1042/cs20160547 · Cited by 8

γ-Aminobutyric Acid Attenuates High-Fat Diet-Induced Cerebral Oxidative Impairment via Enhanced Synthesis of Hippocampal Sulfatides

Si, X., Li, Y., Jiang, Y., Shang, W., Shui, G., Lam, S. M., BLANCHARD, C. L., Strappe, P., & Zhou, Z. (2018) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.8b05246 · Cited by 7

Characterisation of the ligand binding sites in the translocator protein TSPO using the chimeric bacterial-mammalian constructs

Graeber, E., & Korkhov, V. M. (2019) · Protein Expression and Purification · doi:10.1016/j.pep.2019.105456 · Cited by 9

Novel brain PET imaging agents: Strategies for imaging neuroinflammation in Alzheimer’s disease and mild cognitive impairment

Huang, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1010946 · Cited by 7

Biomarkers in Alzheimer’s Disease: Are Olfactory Neuronal Precursors Useful for Antemortem Biomarker Research?

Santillán-Morales, V., Rodríguez-Espinosa, N., Muñoz‐Estrada, J., Alarcón-Elizalde, S., Acebes, Á., & Benítez‐King, G. (2024) · Brain Sciences · doi:10.3390/brainsci14010046 · Cited by 8

Unresponsiveness of Experimental Canine Leishmaniosis to a New Amphotericin B Formulation

Hernández, L., Bolás-Fernández, F., Montoya, A., Checa, R., Dado, D., Gálvez, R., Serrano, D. R., Torrado, J. J., Otranto, D., Latrofa, M. S., et al. (2015) · Advances in Pharmaceutics · doi:10.1155/2015/160208 · Cited by 8

Implementation of [18F]-labeled amyloid brain PET imaging biomarker in the diagnosis of Alzheimer’s disease

Thientunyakit, T., Sethanandha, C., Muangpaisan, W., Chawalparit, O., Arunrungvichian, K., Siriprapa, T., Thongpraparn, T., Chanachai, R., & Gelovani, J. G. (2018) · Nuclear Medicine Communications · doi:10.1097/mnm.0000000000000787 · Cited by 7

Investigation of patterns and associations of neuroinflammation in cognitive impairment

Gan, R., Xie, H., Zhao, Z., Wu, X., Wang, R., Wu, B., Chen, Q., & Jia, Z. (2025) · Cerebral Cortex · doi:10.1093/cercor/bhaf013 · Cited by 7

The engagement of microglia in tau-targeted immunotherapy in Alzheimer’s disease

Palova, D., Csokova, N. T., Markova, K., Kontseková, E., Kováčech, B., & Žilková, M. (2021) · General Physiology and Biophysics · doi:10.4149/gpb_2021029 · Cited by 6

Recent Trends in Nano-Particulate Carriers for the Diagnosis and Treatment of Alzheimer’s Disease

Yadav, A. K., & Mazahir, F. (2022) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527321666220420133059 · Cited by 6

Associations of depressive symptoms with white matter abnormalities and regional cerebral blood flow in patients with amnestic mild cognitive impairment

Hirao, K., Yamashita, F., Kato, H., Kaneshiro, K., Tsugawa, A., Haime, R., Fukasawa, R., Sato, T., Kanetaka, H., Umahara, T., et al. (2022) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.14467 · Cited by 6

Genetic and degenerative disorders primarily causing dementia

Masdeu, J. C., & Pascual, B. (2016) · Handbook of clinical neurology · doi:10.1016/b978-0-444-53485-9.00026-x · Cited by 6

Perspectives in TSPO PET Imaging for Neurologic Diseases

Song, Y. S. (2019) · Nuclear Medicine and Molecular Imaging · doi:10.1007/s13139-019-00620-y · Cited by 6

MRI detects blood-brain barrier alterations in a rat model of Alzheimer’s disease and lung infection

Ohene, Y., Morrey, W. J., Powell, E., Smethers, K. F., Luka, N., South, K., Berks, M., Lawrence, C. B., Parker, G. J. M., Parkes, L. M., et al. (2025) · npj Imaging · doi:10.1038/s44303-025-00071-5 · Cited by 7

Combined Neuroinflammation and Amyloid PET Markers in Predicting Disease Progression in Cognitively Impaired Subjects

Leng, F., Hinz, R., Gentleman, S., Dani, M., Brooks, D. J., & Edison, P. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-230442 · Cited by 5

Hippocampal 1H-MR spectroscopy metabolites are linked to CSF tau pathology in cognitively unimpaired older adults along the Alzheimer’s continuum

Lingad, J. N., Vanderlip, C. R., Wright, S. T., Sordo, L., Head, E., & Stark, C. E. L. (2025) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2025.10.005 · Cited by 5

The Role of Inflammation in Alzheimer’s Disease

Müller, N., Krause, D., Schwarz, M., Weidinger, E., & Reinisch, V. M. (2015) · Current topics in neurotoxicity · doi:10.1007/978-3-319-13602-8_15 · Cited by 5

Neuroprotective Effects of Glucosinolates

Angeloni, C., Hrelia, S., & Malaguti, M. (2016) · Springer eBooks · doi:10.1007/978-3-319-26479-0_20-1 · Cited by 5

The Effects of Crinum asiaticum var. japonicum Baker Seeds on Neuroprotection and Antineuroinflammation in Neuronal Cell Lines

Lim, H.-S., Kim, Y., Kim, Y. J., Sohn, E., Kim, J., & Jeong, S. (2020) · Natural Product Communications · doi:10.1177/1934578x20965465 · Cited by 5

Cognition-enhancing effect of YL-IPA08, a potent ligand for the translocator protein (18 kDa) in the 5 × FAD transgenic mouse model of Alzheimer’s pathology

Dai, W., Yao, R., Mi, T., Zhang, L., Wu, H., Cheng, J., & Li, Y.-F. (2022) · Journal of Psychopharmacology · doi:10.1177/02698811221122008 · Cited by 6

Active Immunization with DNA Vaccine Reduced Cerebral Inflammation and Improved Cognitive Ability in APP/PS1 Transgenic Mice by In Vivo Electroporation

Xing, X., Sha, S., Chen, X.-H., Guo, W., Guo, R., Jiang, T., & Cao, Y. (2015) · Neurochemical Research · doi:10.1007/s11064-015-1559-4 · Cited by 5

Neuroimaging of Alzheimer’s Disease, Mild Cognitive Impairment, and Other Dementias

Risacher, S. L., & Saykin, A. J. (2010) · Springer eBooks · doi:10.1007/978-1-4419-6373-4_19 · Cited by 5

Correction: Age-Dependent Neuroplasticity Mechanisms in Alzheimer Tg2576 Mice Following Modulation of Brain Amyloid-β Levels

Lilja, A. M., Röjdner, J., Mustafiz, T., Thomé, C. M., Storelli, E., Gonzalez, D., Lithner, C. U., Greig, N. H., Nordberg, A. K., & Marutle, A. (2013) · PLoS ONE · doi:10.1371/annotation/79c850e6-4494-4533-b68d-ef4eb72cd65a · Cited by 5

Molecular Imaging of Neuroinflammation in Alzheimer’s Disease and Mild Cognitive Impairment

Kim, J., & Kim, Y. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-981-19-7376-5_14 · Cited by 3

Age‐Dependent Regulation of Hippocampal Inflammation by the Mitochondrial Translocator Protein in Mice

Lai, K. O., Wong, J. H., Tham, N., Fairley, L. H., Naik, R. R., Wang, Y., Langley, S. R., & Barron, A. M. (2025) · Aging Cell · doi:10.1111/acel.70039 · Cited by 4

[PL1‐01]: The relationship between amyloid load, microglial activation, and cognition in Alzheimer's disease: PET findings

Brooks, D. J., Edison, P., Archer, H. A., Hinz, R., Gerhard, A., Hammers, A., Pavese, N., Tai, Y., Cuttler, D., Fox, N. C., et al. (2005) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2005.06.053

Microglial activation in Alzheimer's disease: an (R)-[11C]PK11195 positron emission tomography study

Schuitemaker, A., Kropholler, M. A., Boellaard, R., van der Flier, W. M., Kloet, R. W., van der Doef, T. F., Knol, D. L., Windhorst, A. D., Luurtsema, G., Barkhof, F., et al. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.04.021 · Cited by 175

In vivo changes in microglial activation and amyloid deposits in brain regions with hypometabolism in Alzheimer’s disease

Yokokura, M., Mori, N., Yagi, S., Yoshikawa, E., Kikuchi, M., Yoshihara, Y., Wakuda, T., Sugihara, G., Takebayashi, K., Suda, S., et al. (2011) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-010-1612-0 · Cited by 174

O1–03–01: Microglial activation in patients with mild cognitive impairment and Alzheimer's disease: A study using [11C](R)–PK11195 and PET

Schuitemaker, A., van Berckel, B. N. M., Boellaard, R., Kropholler, M. A., Lubberink, M., Jonker, C., Lammertsma, A. A., & Scheltens, P. (2006) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2006.05.044

Microglial activation and amyloid deposition in mild cognitive impairment: A PET study

Okello, A., Edison, P., Archer, H. A., Turkheimer, F. E., Kennedy, J., Bullock, R., Walker, Z., Kennedy, A., Fox, N., Rossor, M., et al. (2009) · Neurology · doi:10.1212/01.wnl.0000338622.27876.0d · Cited by 367